Skip to main content
    H

    Health In Tech, Inc. Class A Common Stock (HIT)

    Official site

    TECHNOLOGY • SOFTWARE - APPLICATION • NASDAQ

    $0.38
    +0.05 (+15.71%)

    Market Cap: $21.54M

    Last updated: Nov 17, 2026 at 4:43 PM ET

    Health In Tech, Inc. Class A Common Stock (HIT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Health In Tech, Inc. Class A Common Stock (HIT) has a market cap of $21.54M and an enterprise value of $18.05M. Its share count is up 11.78% from a year earlier. It kept -37.22% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 16.20% below the market cap, as cash exceeds debt.

    Market Cap$21.54M
    Enterprise Value$18.05M
    Latest price (Nov 17, 2026)$0.38

    Key Dates

    The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 23, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.40% in the quarter ended Sep 30, 2026 and grew 8.01% a year over 2 years.

    Shares Outstanding63.08M
    Shares Change (YoY)+11.78%
    Shares Change (QoQ)+0.40%
    Share Count Growth (2Y CAGR)+8.01%

    Valuation Ratios

    Sales and book value multiples are 0.8x and 1.9x.

    P/S Ratio0.8x
    Forward P/S0.7x
    P/B Ratio1.9x
    P/TBV Ratio5.1x

    Price Statistics

    The stock is down 76.15% over 52 weeks and trades 45.71% below its 50-day average.

    Beta (1Y)1.31
    52-Week Change-76.15%
    1-Month Change-39.91%
    3-Month Change-62.95%
    6-Month Change-62.22%
    Total Return (1Y)-76.15%
    Max Drawdown (1Y)-83.75%
    Sharpe Ratio (1Y)-1.36
    Correlation with SPY (1Y)0.19
    50-Day Average$0.70
    200-Day Average$1.10
    52-Week Range$0.31 to $2.10
    RSI (14 Days)30.6
    Average Volume (20 Days)78.77K

    Financial Position

    Current assets cover 1.13x current liabilities, and total debt is 0.52x shareholder equity.

    Current Ratio1.13x
    Quick Ratio1.13x
    Debt / Equity0.52x
    Interest Coverage2.55x

    Returns and Efficiency

    Return on invested capital is -60.18% and return on equity is -89.58% over the last 12 months.

    Return on Equity (ROE)-89.58%
    Return on Assets (ROA)-41.05%
    Return on Invested Capital (ROIC)-60.18%
    Asset Turnover1.22x
    Receivables Turnover3.68x

    Scores

    HIT has an Altman Z-Score of 0.03, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score0.03
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $30.92M over the last 12 months is up 0.65% from the 12 months before.

    Revenue$30.92M
    Revenue Growth (YoY)+0.65%
    Gross Profit$15.62M
    Operating Income-$14.16M
    Pretax Income-$15.09M
    Net Income-$11.51M
    EBITDA-$13.96M
    Reported EPS (TTM)-$0.18

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 45.84% of the $28.03M in total assets.

    Cash and Equivalents$10.13M
    Total Debt$6.64M
    Net Cash$3.49M
    Net Cash Per Share$0.06
    Working Capital$1.94M
    Shareholder Equity$12.85M
    Book Value Per Share$0.20
    Tangible Book Value$4.70M
    Tangible Book Per Share$0.07
    Total Assets$28.03M
    Total Liabilities$15.15M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $2.63M of capital spending, operating cash flow left -$9.46M of free cash flow.

    Operating Cash Flow-$6.83M
    Capital Expenditures$2.63M
    Free Cash Flow-$9.46M
    FCF Per Share-$0.18
    Depreciation and Amortization$1.41M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -45.79%.

    Gross Margin50.52%
    Operating Margin-45.79%
    Pretax Margin-48.79%
    Net Margin-37.22%
    EBITDA Margin-45.14%
    FCF Margin-30.59%

    Growth

    Revenue grew 79.42% a year over 3 years.

    Revenue Growth (3Y CAGR)+79.42%
    Operating Income Growth (3Y CAGR)+95.17%
    Book Value Per Share Growth (2Y CAGR)+60.92%
    Tangible Book Per Share Growth (2Y CAGR)+96.31%

    Revenue and profit by year

    Dividends and Yields

    HIT does not pay a dividend. Its free cash flow yield is -39.30%.

    FCF Yield-39.30%
    Buyback Yield-26.81%
    Shareholder Yield-26.81%

    Peer Position

    Against 10 similar companies, HIT has the 8th highest P/S.

    P/S Ratio0.8x vs 1.3x median
    ROIC-60.18% vs -75.40% median
    Revenue Growth (Trailing 4 Quarters, YoY)+0.65% vs +0.80% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About HIT

    What is HIT's market cap?

    Health In Tech, Inc. Class A Common Stock has a market cap of $21.54M. Its enterprise value, which adds debt and subtracts cash, is $18.05M.

    How many shares of HIT are outstanding?

    Health In Tech, Inc. Class A Common Stock has 63.08M shares outstanding. The count is up 11.78% from a year earlier.

    Does HIT pay a dividend?

    No. Health In Tech, Inc. Class A Common Stock does not pay a dividend.

    How much debt does HIT have?

    Health In Tech, Inc. Class A Common Stock has $6.64M of total debt and $10.13M of cash and equivalents, a net cash position of $3.49M.